Holen Sie sich die Stockscreener-App
0.00
100.00%
-8.05
Handel nachbörslich:
8.09
8.09
+
Schlusskurs vom Vortag:
$8.05
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$375.71M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-82.60M
KGV:
0.00
EPS:
-2.06
Netto-Cashflow:
$-48.61M
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
-100.00%
1J Leistung:
-100.00%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$0.00
$0.00
52-Wochen-Spanne:
$0.00
$8.10
Vigil Neuroscience Inc Stock (VIGL) Company Profile
Firmenname
Vigil Neuroscience Inc
Sektor
Branche
Telefon
857-254-4445
Adresse
100 FORGE ROAD, WATERTOWN
Vergleichen Sie VIGL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VIGL
Vigil Neuroscience Inc
|
0.00 | 375.71M | 0 | -82.60M | -48.61M | -2.06 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Vigil Neuroscience Inc Stock (VIGL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-28 | Herabstufung | Stifel | Buy → Hold |
| 2024-12-04 | Eingeleitet | William Blair | Outperform |
| 2023-12-19 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2023-10-18 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-03-31 | Eingeleitet | Mizuho | Buy |
| 2022-09-16 | Eingeleitet | Wedbush | Outperform |
| 2022-08-29 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-02-01 | Eingeleitet | Guggenheim | Buy |
| 2022-02-01 | Eingeleitet | Jefferies | Buy |
| 2022-02-01 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-02-01 | Eingeleitet | Stifel | Buy |
Alle ansehen
Vigil Neuroscience Inc Aktie (VIGL) Neueste Nachrichten
Can Vigil Neuroscience Inc. stock weather global recessionJuly 2025 Highlights & Verified Short-Term Plans - Newser
Is Vigil Neuroscience Inc. stock a buy for dividend growthMarket Activity Summary & Expert Verified Stock Movement Alerts - Newser
Loss Report: How Vigil Neuroscience Inc. stock performs in weak economyJuly 2025 Decliners & Target Return Focused Stock Picks - moha.gov.vn
Can Vigil Neuroscience Inc. stock maintain growth trajectoryJuly 2025 Technicals & Daily Stock Momentum Reports - newser.com
Can Vigil Neuroscience Inc. stock sustain free cash flow growthProfit Target & Trade Opportunity Analysis - newser.com
How Vigil Neuroscience Inc. stock reacts to job market dataTrade Ideas & Daily Stock Momentum Reports - newser.com
Can Vigil Neuroscience Inc. stock deliver surprise earnings beatOptions Play & Weekly Chart Analysis and Guides - newser.com
Using portfolio simulators with Vigil Neuroscience Inc. included - newser.com
Can swing trading help recover from Vigil Neuroscience Inc. losses2025 Technical Overview & Smart Investment Allocation Tips - newser.com
How to interpret RSI for Vigil Neuroscience Inc. stockQuarterly Market Summary & AI Enhanced Execution Alerts - newser.com
Price action breakdown for Vigil Neuroscience Inc.Quarterly Portfolio Review & Reliable Entry Point Alerts - newser.com
Can Vigil Neuroscience Inc. stock sustain institutional interestJuly 2025 Trade Ideas & Entry Point Confirmation Signals - newser.com
How Vigil Neuroscience Inc. stock performs during Fed tightening cyclesTrade Signal Summary & Expert Approved Momentum Trade Ideas - newser.com
Vigil Neuroscience advances Alzheimer's drug to Phase 2 trial - MSN
How to manage a losing position in Vigil Neuroscience Inc.2025 Dividend Review & Technical Buy Zone Confirmation - newser.com
Applying Wyckoff theory to Vigil Neuroscience Inc. stock2025 Performance Recap & High Conviction Investment Ideas - newser.com
Using Bollinger Bands to evaluate Vigil Neuroscience Inc.Product Launch & High Return Trade Opportunity Guides - newser.com
Finanzdaten der Vigil Neuroscience Inc-Aktie (VIGL)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.08%
0.91%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):